NMR in Target Driven Drug Discovery: Why Not?
Overview
Nuclear Medicine
Authors
Affiliations
No matter the source of compounds, drug discovery campaigns focused directly on the target are entirely dependent on a consistent stream of reliable data that reports on how a putative ligand interacts with the protein of interest. The data will derive from many sources including enzyme assays and many types of biophysical binding assays such as TR-FRET, SPR, thermophoresis and many others. Each method has its strengths and weaknesses, but none is as information rich and broadly applicable as NMR. Here we provide a number of examples of the utility of NMR for enabling and providing ongoing support for the early pre-clinical phase of small molecule drug discovery efforts. The examples have been selected for their usefulness in a commercial setting, with full understanding of the need for speed, cost-effectiveness and ease of implementation.
B NMR of the Morphological Evolution of Traditional Chinese Medicine Borax.
Li Q, Yang Y, Wang Q, Han X, Zhu J, Zhang N Molecules. 2024; 29(1).
PMID: 38202834 PMC: 10780283. DOI: 10.3390/molecules29010251.
Technologies for Direct Detection of Covalent Protein-Drug Adducts.
Mons E, Kim R, Mulder M Pharmaceuticals (Basel). 2023; 16(4).
PMID: 37111304 PMC: 10146396. DOI: 10.3390/ph16040547.
NMR Observation of Sulfhydryl Signals in SARS-CoV-2 Main Protease Aids Structural Studies.
Robertson A, Ying J, Bax A Chembiochem. 2022; 23(19):e202200471.
PMID: 35972230 PMC: 9537880. DOI: 10.1002/cbic.202200471.
Estimating the cooperativity of PROTAC-induced ternary complexes using F NMR displacement assay.
de Castro G, Ciulli A RSC Med Chem. 2021; 12(10):1765-1770.
PMID: 34778777 PMC: 8528210. DOI: 10.1039/d1md00215e.
Nassar O, Jouda M, Rapp M, Mager D, Korvink J, MacKinnon N Microsyst Nanoeng. 2021; 7:30.
PMID: 34567744 PMC: 8433180. DOI: 10.1038/s41378-021-00253-2.